Bruker Presents High-Value Life Science, Materials Research and Applied Market Solutions at Analytica 2022

June 21, 2022 – Pharmaceutical


MUNICH, Germany – June 21, 2022: Bruker Corporation (Nasdaq: BRKR) this week displays its high-value scientific instrumentation, software and integrated solutions for applications in materials and energy research, biopharmaceuticals, applied markets, as well as life science and translational research at Analytica 2022.

Frank H. Laukien, PhD, President and CEO of Bruker Corporation, commented: ‘Our differentiated high-value scientific instruments and solutions shown at Analytica 2022 demonstrate the diversity, flexibility and high performance that Bruker brings to the world of laboratory science. Bruker is committed to providing optimized technological, software, chemistry and biology solutions to enable the success of our customers. We are very pleased to introduce novel solutions that now also enable Spatial Single-Cell Metabolomics, a key new capability for in situ, multiomics single-cell biology and cancer research.’

40 Manning Rd, Billerica